- Cash milestones earned from Merck & Incyte
- Three INDs filed and 3 more to be filed during 2018
- CTLA-4 & PD-1 trials treated more than 115 patients; clinical benefit confirmed
PR Newswire
LEXINGTON, Mass., Aug. 9, 2018
PR Newswire
LEXINGTON, Mass., Aug. 9, 2018
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey